4
Changes in Ownership
Astera Labs, Inc. Filed Acc 0001628280-25-029091
Chief Financial Officer sold 500,000 shares at an average $90.23 ($45,113,208)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −19,998 | $88.14 | $1,762,708 | 1,098,998 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −92,200 | $89.05 | $8,210,272 | 1,006,798 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −156,288 | $90.06 | $14,076,047 | 850,510 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −204,954 | $90.75 | $18,599,760 | 645,556 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −15,492 | $92.04 | $1,425,831 | 630,064 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −3,968 | $92.96 | $368,861 | 626,096 | I |
| Tate Michael Truett Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −7,100 | $94.33 | $669,729 | 618,996 | I |
| Open-market sales · 500,000 sh · avg $90.23 · $45,113,208 | |||||||
Loading xslF345X05/wk-form4_1748983198.xml…